To provide a foundational analysis on statistical/causal inference with a focus on the critical assessment of current practices in drug approval and pharmacosurveillance.
To build a unified epistemic framework within which different kinds of evidence for pharmaceutical harm can be combined and used for decision: evidence amalgamation.
To provide a theoretical framework for the development of new standards of drug evaluation.